SR ONE CAPITAL MANAGEMENT, LLC's Net Worth

$0

Estimate Recalculated Nov 1, 2024 05:19AM EST

Who is SR ONE CAPITAL MANAGEMENT, LLC?

SR ONE CAPITAL MANAGEMENT, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcellx, Inc., eFFECTOR Therapeutics, Inc., and Design Therapeutics, Inc..

SEC CIK

SR ONE CAPITAL MANAGEMENT, LLC's CIK is 0001853723

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Arcellx, Inc. (ACLX) Snapshot price: $71.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.42%
-1.01M
$45.01
-$45,589,317.35
4.49M
May 11
Form 4
∞
5.5M
$15.00
—
5.5M
Feb 8
Form 3
—
0
—
—
0
No matching records found

eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $0.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-8.93%
-609.16K
$0.61
-$369,457.36
6.21M
Nov 27
Form 3
—
0
—
—
0
No matching records found

Zenas BioPharma, Inc. (ZBIO) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4.91M
$17.00
—
4.91M
Sep 16
Form 3
—
0
—
—
0
No matching records found

Design Therapeutics, Inc. (DSGN) Snapshot price: $4.67

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+16.00%
900K
$8.42
$7,574,078.00
6.53M
Dec 16 - Dec 20
Form 4
∞
5.63M
$20.00
—
5.63M
Mar 30
Form 3/A
—
0
—
—
0
No matching records found